{Reference Type}: English Abstract
{Title}: [Clinical case: early connection of valsartan/sacubitril in the treatment of hypertension].
{Author}: Lozhkina NG;Spiridonov AN;Lozhkina NG;Spiridonov AN;
{Journal}: Kardiologiia
{Volume}: 62
{Issue}: 5
{Year}: May 2022 31
{Factor}: 0.513
{DOI}: 10.18087/cardio.2022.5.n1977
{Abstract}: Metabolic syndrome is a disease the World Health Organization has called a new pandemic of the 21st century. Arterial hypertension is one of the criteria for this diagnosis and a determinant of damage to major target organs. The present clinical case demonstrates an experience of treatment of arterial hypertension associated with metabolic syndrome with a valsartan/sacubitril molecular complex.